What's In A Name? FDA Offers More Clarity On The Device-Drug Dividing Line
This article was originally published in The Gray Sheet
Executive Summary
Recognizing the blurred distinction between some advanced device and drug technologies, FDA has released a pair of draft guidance documents to clarify where certain medical products fall within the agency's regulatory scheme.